Page last updated: 2024-08-17

nad and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

nad has been researched along with 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Biswas, N; Das, A; Ghosh, N; Gnyawali, S; Gorain, M; Khanna, S; Polcyn, C; Roy, S; Sen, CK; Singh, K	1
Bae, SJ; Dao, T; Gariani, K; Green, AE; Ha, KT; Kim, YA; Lee, MR; Menzies, KJ; Ryu, D	1

Reviews

1 review(s) available for nad and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

Article	Year
Sarcopenia and Muscle Aging: A Brief Overview. Endocrinology and metabolism (Seoul, Korea), 2020, Volume: 35, Issue:4 Topics: Aged; Aging; Animals; Coumarins; Gastrointestinal Microbiome; Humans; Mitochondria; Mitophagy; Muscle, Skeletal; NAD; Sarcopenia	2020

Other Studies

1 other study(ies) available for nad and 3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one

Article	Year
Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD Scientific reports, 2020, 11-19, Volume: 10, Issue:1 Topics: Adenosine Triphosphate; Administration, Oral; Animals; Coumarins; Gene Expression Profiling; Male; Mice, Inbred C57BL; Muscle, Skeletal; NAD; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reproducibility of Results; Sirtuin 1	2020

Article

Year

Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD

Scientific reports, 2020, 11-19, Volume: 10, Issue:1

Topics: Adenosine Triphosphate; Administration, Oral; Animals; Coumarins; Gene Expression Profiling; Male; Mice, Inbred C57BL; Muscle, Skeletal; NAD; Neovascularization, Physiologic; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reproducibility of Results; Sirtuin 1

2020